drugs such as antibodies or small molecule inhibitors. However, nowadays it is possible to search for biological agents or small molecules that can functionally replace (or mimic) the lost tumor suppressor

methods range from molecular biology, biochemistry, tumor and primary cell culture to animal models. For more information please see the individual links of all the group leaders ( team ). Here all the names

Michel TM, Sheldrick AJ, Schneider F. From psychosurgery to neuromodulation: Deep brain stimulation for intractable Tourette syndrome. World J Biol Psychiatry. 2009; 10: 366-376. Neuner I, Ludolph A . T

Forschung Neuropädiatrie

Prempeh P, Backes V, Finkelmeyer A, Schneider F, Habel U. Empathy in individuals clinically at risk for psychosis: brain and behaviour. Br J Psychiatry 2015; 207(5): 407-13. Backes V, Kellermann T, Voss [...] Kircher TT, Habel U. The interaction of working memory and emotion in persons clinically at risk for psychosis: An fMRI pilot study. Schizophr Res 2010; 120: 167-176. Eickhoff S, Backes V, Schneider F

Jahnen-Dechent W, Wolf M and Neuss S. Identifying Differences in Molecular Characteristics Relevant for Remodeling of Periodontal Ligament Stem Cells from the Upper and Lower Jaw. Int J Mol Sci . 2024;25 [...] Oncol . 2024. 4. van der Vorst EPC and Kovacic JC. Therapeutic targeting of cell transition: ready for clinical prime-time? Cardiovasc Res . 2024. 5. Christ A, Maas SL, Jin H, Lu C, Legein B, Wijnands E [...] Trautwein C and Bartneck M. Targeting Ligand Independent Tropism of siRNA-LNP by Small Molecules for Directed Therapy of Liver or Myeloid Immune Cells. Adv Healthc Mater . 2023:e2202670. Maas SL and van

DIZ Aachen ist ein Kooperationspartner des SMITH-Konsortiums – Smart Medical Information Technology for Healthcare - eines von vier durch die MII geförderten Konsortien. Das Datenintegrationszentrum ist

von Medizinerinnen und Medizinern entstanden, die sich bei den Fortbildungen der European Academy for Medicine of Ageing (EAMA) kennengelernt hatten und sich innerhalb Deutschlands interdisziplinär vernetzen

. We are an interdisciplinary international team of researchers striving to develop new therapies for GI diseases by decoding molecular circuits of organ crosstalk. We conduct research on the gut-liver

Clinic II (Nephrology) and Ass.-Prof. Dr. med. Peter Boor, Ph.D. from the Institute of Pathology. For more information about REMAP, please visit www.remapnet.eu or contact info remapnet eu .